CE mark for Angeion's AngePass Lead System:
This article was originally published in Clinica
Angeion has CE-marked its AngePass lead system which comprises both 4040 and 4080 models in the AngePass series. It is designed to lower energy thresholds required to convert critical cardiac arrhythmias to normal rhythm and intended for use with the company's Small Cap and Tuned biphasic waveform. The 4040 offers a tined passive fixation tip and is placed in the apex of the right ventricle. Alternatively, it could be augmented with the 4080 which is placed in the superior vena cava.